Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment

ConclusionDosing of drugs used to treat COVID-19 in patients with renal or hepatic impairment is complex. These recommendations were produced to provide guidance to clinicians worldwide who are treating patients with COVID-19, many of whom will have some degree of acute or chronic renal or hepatic impairment.
Source: Drugs in R&D - Category: Drugs & Pharmacology Source Type: research